Sania Therapeutics
Sania Therapeutics is focused on developing medicines for treating neural circuit dysfunctions. Their therapies combine targeted delivery with controllable therapeutics for the treatment of nervous system disorders.
- Precision therapies
- Targeted delivery systems
- Therapeutics for nervous system disorders
Locations
Digital Popularity
Social Media
Company Details
Sania Therapeutics is operated by Ultimate Associates Ltd and is a Active company incorporated on 25 July 2007 with the registered office located in Sheerness, Kent. Ultimate Associates Ltd was registered 18 years ago.
Status
Active
Size
Micro
Directors
1
Age
18 years old
Employees
1
Turnover
Unreported
Total Assets
£875
Cash in Bank
Unreported
Total Liabilities
-£8.88K
Teams
19
9
9
5
3
1
3
CEO And Founder • Joined Apr 2021
Co-founder • Joined Nov 2021
Principal Scientist • Joined Sep 2024
Chief Operating Officer • Joined May 2024
Head Of Chemogenetic Neuromodulation • Joined May 2023
Head Of Vector Development • Joined Apr 2023
Director Of Early Research • Joined Sep 2024
Staff Scientist III And Operations Manager • Joined May 2024
Business Operations Administrator & PA • Joined Aug 2024
Scientific Advisory Board Member • Joined May 2023
Principal Scientist • Joined Sep 2024
Director Of Early Research • Joined Sep 2024
Staff Scientist II • Joined Sep 2023
Staff Scientist I • Joined Jun 2024
Staff Scientist II • Joined Jul 2024
Staff Scientist II • Joined Jun 2023
Research Scientist • Joined Aug 2024
Scientist • Joined Jul 2022
Staff Scientist II • Joined Jul 2024
Principal Scientist • Joined Sep 2024
Staff Scientist II • Joined Sep 2023
Staff Scientist I • Joined Jun 2024
Staff Scientist II • Joined Jul 2024
Staff Scientist II • Joined Jun 2023
Scientific Advisor • Joined Nov 2022
Research Scientist • Joined Aug 2024
Scientist • Joined Jul 2022
Staff Scientist II • Joined Jul 2024
CEO And Founder • Joined Apr 2021
Co-founder • Joined Nov 2021
Chief Operating Officer • Joined May 2024
Director Of Early Research • Joined Sep 2024
Board Member, Investor • Joined Jan 2022
Co-founder • Joined Nov 2021
Scientific Advisory Board Member • Joined May 2023
Board Member, Investor • Joined Jan 2022
Business Operations Administrator & PA • Joined Aug 2024
Head Of Chemogenetic Neuromodulation • Joined May 2023
Head Of Vector Development • Joined Apr 2023
Staff Scientist III And Operations Manager • Joined May 2024
View 19 members